Finance

Lists
I1SR34:BVMF
Intuitive Surgical Inc Bdr
R$106,10
0,00%
(0,00) 1D
9 Okt., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for I1SR34...
Open
R$106,50
High
R$106,50
Low
R$105,40
Mkt. cap
149,78 mjd
Avg. vol.
1,56 k
Volume
1,36 k
52-wk high
R$162,55
52-wk low
R$83,81
Shares outstanding
353,28 m
No. of employees
17 k
Open
R$106,50
High
R$106,50
Low
R$105,40
Mkt. cap
149,78 mjd
Avg. vol.
1,56 k
Volume
1,36 k
52-wk high
R$162,55
52-wk low
R$83,81
Shares outstanding
353,28 m
No. of employees
17 k
News stories
From web sources and news partners
Profile
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world. Intuitive Surgical first appeared on the Fortune 500 in 2024 at number 497; in 2025 the company rose to number 459 overall and ranked 43rd within the healthcare sector. Wikipedia
About Intuitive Surgical Inc Bdr
CEODavid J. Rosa
Employees17 k
Founded1995
HeadquartersSunnyvale, Kalifornië, Verenigde State van Amerika
SectorMedical device
Website-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,51 mjd
2,87 mjd
2,77 mjd
2,89 mjd
Cost of goods sold
842,70 m
961,90 m
940,30 m
931,90 m
Cost of revenue
842,70 m
961,90 m
940,30 m
931,90 m
Research and development expenses
329,40 m
352,90 m
361,90 m
370,60 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
573,30 m
687,10 m
613,30 m
617,90 m
Operating expense
902,70 m
1,04 mjd
975,20 m
988,50 m
Total operating expenses
1,75 mjd
2,00 mjd
1,92 mjd
1,92 mjd
Operating income
759,70 m
864,30 m
855,30 m
971,90 m
Other non operating income
-
-
-
-
EBT including unusual items
855,20 m
955,60 m
940,40 m
1,05 mjd
EBT excluding unusual items
855,20 m
950,90 m
939,80 m
1,05 mjd
Income tax expense
146,00 m
156,10 m
114,40 m
231,40 m
Effective tax rate
17,07%
16,34%
12,16%
21,94%
Other operating expenses
-
-
-
-
Net income
704,40 m
794,80 m
821,50 m
818,10 m
Net profit margin
28,12%
27,73%
29,65%
28,29%
Earnings per share
2,40
2,53
2,50
2,80
Interest and investment income
82,30 m
77,50 m
85,70 m
81,10 m
Interest expense
-
-
-
-
Net interest expenses
82,30 m
77,50 m
85,70 m
81,10 m
Depreciation and amortization charges
-
-
-
-
EBITDA
919,70 m
1,02 mjd
1,06 mjd
1,20 mjd
Gain or loss from assets sale
-
13,70 m
-7,90 m
-
AI content may include mistakes. Learn more
Google-programme